Mitochondrial ROS Drive Sudden Cardiac Death and Chronic Proteome Remodeling in Heart Failure

about

Arrhythmogenic Mechanisms in Heart Failure: Linking β-Adrenergic Stimulation, Stretch, and Calcium

P2860

Q58121711-5B88BFBE-9223-43CD-826E-8A74C27F7F0C

P2860

Mitochondrial ROS Drive Sudden Cardiac Death and Chronic Proteome Remodeling in Heart Failure

Item

http://www.wikidata.org/entity/Q57095732

description

im Juli 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в липні 2018

@uk

name

Mitochondrial ROS Drive Sudden ...... me Remodeling in Heart Failure

@en

Mitochondrial ROS Drive Sudden ...... me Remodeling in Heart Failure

@nl

type

Item

label

Mitochondrial ROS Drive Sudden ...... me Remodeling in Heart Failure

@en

Mitochondrial ROS Drive Sudden ...... me Remodeling in Heart Failure

@nl

prefLabel

Mitochondrial ROS Drive Sudden ...... me Remodeling in Heart Failure

@en

Mitochondrial ROS Drive Sudden ...... me Remodeling in Heart Failure

@nl

P1476

Mitochondrial ROS Drive Sudden ...... me Remodeling in Heart Failure

@en

P2093

Agnieszka Sidor

http://www.w3.org/2001/XMLSchema#string

Brian O'Rourke

http://www.w3.org/2001/XMLSchema#string

D Brian Foster

http://www.w3.org/2001/XMLSchema#string

Deeptankar DeMazumder

http://www.w3.org/2001/XMLSchema#string

Swati Dey

http://www.w3.org/2001/XMLSchema#string

P2860

Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial

Targeting mitochondrial cardiolipin and the cytochrome c/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis

First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics

The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin

Cross talk between mitochondria and NADPH oxidases

Therapeutic inhibition of mitochondrial reactive oxygen species with mito-TEMPO reduces diabetic cardiomyopathy

DUSP6 (MKP3) null mice show enhanced ERK1/2 phosphorylation at baseline and increased myocyte proliferation in the heart affecting disease susceptibility

Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro

Entropy of cardiac repolarization predicts ventricular arrhythmias and mortality in patients receiving an implantable cardioverter-defibrillator for primary prevention of sudden death.

The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries.

P304

356-371

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCRESAHA.118.312708

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P577

2018-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29898892

http://www.w3.org/2001/XMLSchema#string

P921

mitochondrion

P932

6057154

http://www.w3.org/2001/XMLSchema#string

Mitochondrial ROS Drive Sudden Cardiac Death and Chronic Proteome Remodeling in Heart Failure

about

P2860

P2860

Mitochondrial ROS Drive Sudden Cardiac Death and Chronic Proteome Remodeling in Heart Failure

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932